Deutsche Bank initiated coverage of Acadia Pharmaceuticals (ACAD) with a Hold rating and $22 price target Maximize Your Portfolio with Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback